Hjem › Lungekreft › Colorado › Denver
Kliniske studier for Lungekreft i Denver, CO
16 studier for Lungekreft søker deltakere på steder i og rundt Denver (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Kaiser Permanente-Franklin, Denver
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Kaiser Permanente-Franklin, Denver
- National Jewish Health-Main Campus, Denver
- Rocky Mountain Cancer Centers - Swedish, Englewood · 6 mi unna
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekruttererFase 3
- Kaiser Permanente-Franklin, Denver
- Rocky Mountain Cancer Centers - Swedish, Englewood · 6 mi unna
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- Rocky Mountain Cancer Center, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- AdventHealth Porter, Denver
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruttererFase 3
- Kaiser Permanente-Franklin, Denver
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RekruttererFase 1
- Presbyterian/St Lukes Medical Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Sarah Cannon Research Institute at HealthOne, Denver
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekruttererFase 1/2
- Avenzo Therapeutics Recruiting Site, Denver
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RekruttererFase 1
- Sarah Cannon Research Institute - Denver DDU, Denver
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekruttererFase 3
- UCHealth - Cherry Creek, Denver
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RekruttererFase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RekruttererFase 1
- Sarah Cannon, SCRI Oncology Partners - Health One, Denver
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RekruttererFase 1/2
- Sarah Cannon Research Institute Denver, Denver
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Sarah Cannon Research Institute (SCRI) at HealthONE, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Denver
Lungekreft-studier i andre byer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Arlington, VA41 studier
- Washington, DC41 studier
- Chicago, IL41 studier
- Baltimore, MD40 studier
- Nashville, TN40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andre studier i Denver
- Metastatisk kreft29 studier
- Brystkreft29 studier
- Ikke-småcellet lungekreft27 studier
- Multipelt myelom27 studier
- Kolorektal kreft23 studier
- Melanom19 studier
- Prostatakreft19 studier
- Kreft (alle typer)18 studier
- Eggstokkreft16 studier
- Endometriekreft15 studier
- Non-Hodgkins lymfom14 studier
- Pankreaskreft13 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.